Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Avaliação da acurácia da reação em cadeia de polimerase em tempo real (QPCR) para o diagnóstico da hanseníase no soro de sangue periférico

Monteiro C. B. L. de C. Universidade de Brasilia. 2022;
Download PDF
Publication

Target product profile for a diagnostic test to detect Mycobacterium leprae infection among asymptomatic household and familial contacts of leprosy patients

World Health Organization . World Health Organization . 2023;
Download PDF
Publication

Target product profile for a diagnostic test to confirm leprosy in individuals with clinical signs and symptoms

World Health Organization . World Health Organization . 2023;
Download PDF
Publication

Hanseníase e testes diagnósticos rápidos: desafios e gestão de ciência, tecnologia & inovação em saúde

De Melo LC, Campos Meiado A, Gomes de Andrade VL, et al. Escola de Saude Publica Visconde Saboia. SANARE - Revista de Políticas Públicas. 2023; 22 (1) : 60-66.
Download PDF
Publication

Leprosy Skin Lesion Detection: An AI Approach Using Few Shot Learning in a Small Clinical Dataset

Beesetty R, Reddy S. A, Modali S, et al. Hind Kusht Nivaran Sang. Indian Journal of Leprosy. 2023;
Download PDF
Publication

Is the future of leprosy care digital?

Quilter EEV, Butlin C. Lepra. Leprosy Review. 2023; 94 (2) : 182-184.
Download PDF
Publication

Leprosy among children in an area without primary health care coverage in Caratateua Island, Brazilian Amazon

Costa ILV, da Costa PF, da Silva SM, et al. Frontiers Media SA. Frontiers in Medicine. 2023;
Download PDF
Publication

Quantitative Real-Time Polymerase Chain Reaction for Detection of Mycobacterium leprae DNA in Tissue Specimens from Patients with Leprosy.

Sarath I, Joseph N, Jamir I. The American journal of tropical medicine and hygiene. 2023;
Publication

Systematic Review of Hansen Disease Attributed to Mycobacterium lepromatosis.

Collin S, Lima A, Heringer S, et al. Emerging infectious diseases. 2023; 29 (7) : 1376-1385.
Download PDF
Publication

Casos de lepra diagnosticados en la unidad de biología molecular del sanatorio Fontilles

Acosta L. Revista de Leprología. 2022; 33 (4) : 277-286.

Pagination

  • Previous page ‹‹
  • Page 12
  • Next page ››
Subscribe to Diagnostic tests

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD